These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 10707832)

  • 41. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
    Mai KT; Yazdi HM; Farmer J
    Prostate; 2001 May; 47(3):172-82. PubMed ID: 11351346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study.
    Erbersdobler A; Isbarn H; Steiner I; Schlomm T; Chun F; Mirlacher M; Sauter G
    Urology; 2009 Nov; 74(5):1169-73. PubMed ID: 19476978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
    Shariat SF; Roudier MP; Wilcox GE; Kattan MW; Scardino PT; Vessella RL; Erdamar S; Nguyen C; Wheeler TM; Slawin KM
    Cancer Res; 2003 Aug; 63(15):4662-70. PubMed ID: 12907647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer.
    Bobinac D; Marić I; Zoricić S; Spanjol J; Dordević G; Mustać E; Fuckar Z
    Croat Med J; 2005 Jun; 46(3):389-96. PubMed ID: 15861517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
    Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
    Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
    Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.
    Fujii Y; Kawakami S; Okada Y; Kageyama Y; Kihara K
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E927-31. PubMed ID: 14761877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prostate specific antigen: a role of PSA in the diagnosis of prostate cancer].
    Nutahara K; Higashihara E
    Rinsho Byori; 2001 Oct; 49(10):963-6. PubMed ID: 11769472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues.
    Howarth DJ; Aronson IB; Diamandis EP
    Br J Cancer; 1997; 75(11):1646-51. PubMed ID: 9184181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of androgen receptor and prostate-specific antigen in male breast carcinoma.
    Kidwai N; Gong Y; Sun X; Deshpande CG; Yeldandi AV; Rao MS; Badve S
    Breast Cancer Res; 2004; 6(1):R18-23. PubMed ID: 14680496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?
    Mannello F; Gazzanelli G
    Breast Cancer Res; 2001; 3(4):238-43. PubMed ID: 11434875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential distribution of soluble and complexed forms of prostate-specific antigen in cyst fluids of women with gross cystic breast disease.
    Malatesta M; Mannello F; Sebastiani M; Gazzanelli G
    J Clin Lab Anal; 2001; 15(2):81-6. PubMed ID: 11291110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of long-term androgen administration on breast tissue of female-to-male transsexuals.
    Slagter MH; Gooren LJ; Scorilas A; Petraki CD; Diamandis EP
    J Histochem Cytochem; 2006 Aug; 54(8):905-10. PubMed ID: 16618941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical implications of prostate-specific antigen in men and women.
    Yu H
    J Gend Specif Med; 2000; 3(2):45-8, 53. PubMed ID: 11253246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The normal female and the male breast epithelium does not express prostate-specific antigen. Preliminary immunohistochemical observations of autopsy breast tissues.
    Zaviacic M; Ablin RJ; Ruzicková M; Stvrtina S; Danihel L; Zaviacic T; Pohlodek K; Holomán K
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():41-4. PubMed ID: 10707832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of NKX3.1 in normal and malignant tissues.
    Gelmann EP; Bowen C; Bubendorf L
    Prostate; 2003 May; 55(2):111-7. PubMed ID: 12661036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast conditions.
    Nariţa D; Raica M; Anghel A; Suciu C; Cîmpean A
    Rom J Morphol Embryol; 2005; 46(1):41-5. PubMed ID: 16286983
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.